GURUFOCUS.COM » STOCK LIST » USA » NAS » Regeneron Pharmaceuticals Inc (NAS:REGN) » Definitions » Profitability Rank
Switch to:

Regeneron Pharmaceuticals Profitability Rank

: 9 (As of Jun. 2022)
View and export this data going back to 1991. Start your Free Trial

Regeneron Pharmaceuticals has the Profitability Rank of 9. It has a higher profitability and may stay that way.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Regeneron Pharmaceuticals's Operating Margin % for the quarter that ended in Jun. 2022 was 45.74%. As of today, Regeneron Pharmaceuticals's Piotroski F-Score is 5.


Competitive Comparison

For the Biotechnology subindustry, Regeneron Pharmaceuticals's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Regeneron Pharmaceuticals Profitability Rank Distribution

For the Biotechnology industry and Healthcare sector, Regeneron Pharmaceuticals's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Regeneron Pharmaceuticals's Profitability Rank falls into.



Regeneron Pharmaceuticals Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Regeneron Pharmaceuticals has the Profitability Rank of 9. It has a higher profitability and may stay that way.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Regeneron Pharmaceuticals's Operating Margin % for the quarter that ended in Jun. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2022 ) / Revenue (Q: Jun. 2022 )
=1306.9 / 2857.2
=45.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Regeneron Pharmaceuticals has an F-score of 5 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Good Sign:

Regeneron Pharmaceuticals Inc operating margin is expanding. Margin expansion is usually a good sign.

4. Consistency of the profitability

5. Predictability Rank


Regeneron Pharmaceuticals Profitability Rank Related Terms

Thank you for viewing the detailed overview of Regeneron Pharmaceuticals's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Regeneron Pharmaceuticals Business Description

Regeneron Pharmaceuticals logo
Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.
Executives
Schleifer Leonard S director, officer: President & CEO 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Van Plew Daniel P officer: EVP & General Mgr Industrial O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Yancopoulos George director, officer: President and CSO
Murphy Andrew J officer: EVP Research REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Mccourt Marion officer: SVP Commercial C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Fenimore Christopher R. officer: VP, Controller REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Coles N Anthony director MORRIS CORP. CENTER I; BLDG. B; 4TH FLR. 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Zoghbi Huda Y director REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Bassler Bonnie L director REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Ingram Robert Alexander director 280 S. MANGUM STREET SUITE 350 DURHAM NC 27701
Sanofi 10 percent owner 54 RUE LA BOETIE PARIS I0 75008
Landry Robert E officer: SVP Fin, Dep CFO 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Tessier-lavigne Marc director 1 DNA WAY SOUTH SAN FRANCISCO CA 94080
Larosa Joseph J officer: SVP Gen Counsel & Secretary 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Poon Christine A director C/O JOHNSON & JOHNSON ONE JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Regeneron Pharmaceuticals Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)